{"id":"NCT02488330","sponsor":"Hoffmann-La Roche","briefTitle":"An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study","officialTitle":"An Open-label, Multicenter Extension Study of Onartuzumab in Patients With Solid Tumors on Study Treatment Previously Enrolled in an F.Hoffmann-la Roche- and/or Genentech- Sponsored Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-08-27","primaryCompletion":"2018-06-29","completion":"2018-06-29","firstPosted":"2015-07-02","resultsPosted":"2019-07-23","lastUpdate":"2019-07-23"},"enrollment":12,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Solid Tumor"],"interventions":[{"type":"DRUG","name":"Onartuzumab","otherNames":[]},{"type":"DRUG","name":"Bevacizumab","otherNames":["Avastin"]},{"type":"DRUG","name":"Erlotinib","otherNames":["Tarceva"]}],"arms":[{"label":"Control and/or Onartuzumab treatment","type":"EXPERIMENTAL"}],"summary":"This extension study will provide continued onartuzumab and/or parent trial (P-trial) designated control treatments to participants with cancer who were previously enrolled in a company-sponsored onartuzumab P-trial and who derived benefit, as assessed by the responsible investigator, from the therapy administered in the P-trial. The study will also collect safety data with regard to administration of continued onartuzumab therapy.","primaryOutcome":{"measure":"Percentage of Participants With Serious Adverse Events Considered Related to Onartuzumab","timeFrame":"Baseline through the end of trial (approximately 3 years)","effectByArm":[{"arm":"Control and/or Onartuzumab Treatment","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":2},"locations":{"siteCount":10,"countries":["France","Italy","Japan","Latvia","Russia","Serbia","South Africa","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":12},"commonTop":[]}}